But there is evidence that the connection between epilepsy and depression may be a two-way street, according to research carried out in Sweden and the United States and reviewed at the annual meeting of the American Association for the Advancement of Science (AAAS).
"People with a history of depression have a 3 to 7 times higher risk of developing epilepsy," said Dr. Andres Kanner, a specialist on epilepsy at Rush University Medical Center in Chicago. "This kind of information is forcing us to take a second look at the interaction between depression and epilepsy."
Since depression affects about 5.3 percent of the U.S. population and epilepsy about 0.5 to 1 percent, session organizers said, knowledge of any relationships between the two disorders could help physicians find ways to improve care for both groups. The two-way relationship between epilepsy and depression could mean common pathogenic mechanisms are at work, Kanner said.
Studies with rats that are genetically prone to epilepsy show abnormal secretion in the brain of neurotransmitters such as serotonin, norepinephrine, GABA and dopamine. The abnormal secretion patterns of serotonin and norepinephrine in these animals are similar to abnormal patterns for the same neurotransmitters seen in patients with depression, Kanner said. He summarized the evidence for common biological pathways in a paper published in January in the journal Epilepsy Currents. Phillip C. Jobe of the University of Illinois College of Medicine, another speaker at the meeting, also has studied underlying biological factors that may predispose some people to epilepsy and depression.
Common pathways between depression and epilepsy might account for recent data suggesting that patients with a psychiatric history may not respond as well to medication or surgery for treatment of their seizures, Kanner said. He and his colleagues recently studied 90 patients whose seizures failed to respond to antiepileptic medication and underwent brain surgery to remove tissue that was the focus of the seizures. Patients with a lifetime history of depression were less likely to become seizure-free, the researchers found. Kanner said that suggests depression could be a biological marker for a more severe form of epilepsy.
Epilepsy, marked by unprovoked seizures, is caused by recurrent electrical "storms" in the brain. More than 2.5 million Americans of all ages are living with epilepsy, which can develop at any time of life but especially in early childhood and old age, according to the Epilepsy Foundation.
Possible links between depression and epilepsy have been noted since around 400 B.C., when Hippocrates, the Greek physician, reportedly observed, "Melancholics ordinarily become epileptics and epileptics melancholics." Galen, another Greek physician, later wrote a treatise titled "Epilepsy and Melancholy."
Whatever biological links the two disorders may share, clinicians and patients alike need to be more aware of the significant incidence of depression among those with epilepsy, says Dr. Alan Ettinger of the Long Island Jewish Comprehensive Epilepsy Center. That is true, he said, even of patients who exhibit less severe forms of the condition than those treated at specialized clinics and major medical centers.
Ettinger and his colleagues surveyed 775 epilepsy patients in community settings, 395 asthma patients and 362 healthy control subjects. Among those with epilepsy, 36.5 percent reported symptoms of depression, compared to 27.8 percent of asthmatics and 11.8 percent of controls. The study, published in the journal Neurology in September, also found that nearly 39 percent of the patients with epilepsy had never been evaluated for depression. Ettinger said it is important for doctors and patients to understand that those with epilepsy, even mild forms of the condition, face an elevated risk of depression.
"Patients with epilepsy usually respond well to anti-depression medication and with lower doses," Kanner said. "There is a lot of misperception that if you use an antidepressant, it will worsen the seizures. That is not really so." Kanner said a class of drugs called selective serotonin reuptake inhibitors (which include Zoloft, Paxil and Prozac) have proved safe in patients with epilepsy.
The American Association for the Advancement of Science (AAAS) is the world's largest general scientific society, and publisher of the journal, Science (www.sciencemag.org). AAAS was founded in 1848, and serves some 262 affiliated societies and academies of science, including 10 million individuals. Science has the largest paid circulation of any peer-reviewed general science journal in the world, with an estimated total readership of one million. The non-profit AAAS (www.aaas.org) is open to all and fulfills its mission to "advance science and serve society" through initiatives in science policy; international programs; science education; and more. For the latest research news, log onto EurekAlert!, www.eurekalert.org, the premier science-news Web site, a service of AAAS.
Additional news from the AAAS Annual Meeting may be found online at www.eurekalert.org.
MEDIA NOTE: A news briefing on this research will take place at 3:00 p.m. Eastern Time, Friday, 18 February, during the AAAS Annual Meeting in Washington, DC, in Wilson A of the Marriott Wardman Park Hotel. Further, these and other speakers will take part in a symposium titled, "Can Studying Epilepsy Lead to Improved Knowledge About Depression? set to take place Friday at 8:30 a.m. in the Marriott Wardman Park Hotel, Lobby Level, Marriott Ballroom Salon 1.
Press registration is located in the AAAS Press Center in the Taft Room of the Marriott Wardman Park Hotel.
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.